FDA approval of nevirapine for HIV
American Family Physician 54(5): 1805-1806
1996
ISSN/ISBN: 0002-838X PMID: 8857799 Document Number: 467625
Document emailed within 1 workday
Related Documents
Cohen, M.H.; Johnson, J.R.; Pazdur, R. 2005: U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(1): 12-19Flys, T.S.; McConnell, M.S.; Matovu, F.; Church, J.D.; Bagenda, D.; Khaki, L.; Bakaki, P.; Thigpen, M.C.; Eure, C.; Fowler, M.Glenn.; Eshleman, S.H. 2008: Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission Journal of Infectious Diseases 198(4): 465-469
Jørgensen, L.B.; Katzenstein, T.L.; Gerstoft, J.; Mathiesen, L.R.; Pedersen, C.; Nielsen, C. 2000: Genotypic and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine Antiviral Therapy 5(3): 187-194
Manosuthi, W.; Kiertiburanakul, S.; Chaovavanich, A.; Sungkanuparph, S. 2007: Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients Journal of the Medical Association of Thailand 90(2): 244-250
Zijenah, L.S.; Kadzirange, G.; Rusakaniko, S.; Kufa, T.; Gonah, N.; Tobaiwa, O.; Gwanzura, C.; Matsikire, E.; Katzenstein, D.A. 2006: A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, Zimbabwe Central African Journal of Medicine 52(1-2): 1-8
Imperiale, M. 2002: Nevirapine-associated toxicity Aids Reader 12(4): 171
Fischer, R.G. 1987: The meaning of FDA approval Pediatric Nursing 13(5): 360
1992: Approval for broader use of DDI American Family Physician 46(6): 1841-1842
Morley, R.; Grover, S.R.; Kilpatrick, N.; Hamilton, M. 2001: Retrospective ethical approval Medical Journal of Australia 175(5): 286-287
Botstein, P. 1986: Evidence used for approval of new drugs Israel Journal of Medical Sciences 22(3-4): 197-200
Sitruk-Ware, R. 2000: Approval of mifepristone (RU 486) in Europe Zentralblatt für Gynakologie 122(5): 241-247
Hempel, S. 1991: A faint chorus of approval Nursing Times 87(34): 16-17
Kristensen, K. 1996: Approval of radioactive drugs Ugeskrift for Laeger 158(34): 4734
Gifford, R.W. 1980: The FDA new drug approval process Connecticut Medicine 44(5): 309-311
Shegokar, R.; Singh, K.K. 2011: Nevirapine nanosuspensions for HIV reservoir targeting Die Pharmazie 66(6): 408-415
Phadke, M.A.; Bulakh, P.M.; Kshirsagar, N.A. 2008: Nevirapine to prevent HIV transmission via breastfeeding Lancet 372(9635): 287
Hunt, J. 1997: The importance of obtaining ethical approval Professional Nurse 12(12): 890
Ionas, V.M.; Modl', A.A. 1979: Approval of inventions in the field of medicine Sovetskaia Meditsina 11: 94-98
1988: Approval of a new oral contraceptive, 1988 Annual Review of Population Law 15: 16
Lewis, C. 2003: FDA begins product approval initiative Fda Consumer 37(3): 10-11